Our Mission

To make prescription drugs more affordable for all Americans. CSRxP advocates for bipartisan solutions that hold pharmaceutical companies accountable for out-of-control drug prices and provide more affordable choices for patients. We believe in market-based reforms that address the underlying causes of high drug prices in the U.S. through increased transparency, competition, and value.

Learn More

BIG PHARMA EARNINGS WATCH: ABBVIE, ASTRAZENECA, AMGEN

Big Pharma Drugmakers Top Wall Street Estimates After Hiking Drug Prices Earlier This Year This week, brand name drug giants AbbVie, AstraZeneca and Amgen all announced earnings and profits for the

08-5-2022 Read More

SECOND OPINION: PHRMA’S LAST-DITCH ATTEMPT TO DERAIL SOLUTIONS TO LOWER DRUG PRICES REHASHES DEBUNKED ARGUMENTS

Pharmaceutical Industry Attempts to Intimidate Lawmakers and Keep Prices High by Re-Upping False Claims, Blame Game and Discredited Innovation Rhetoric On Thursday

08-5-2022 Read More

ICYMI: CIVICASCRIPT BRINGS FIRST GENERIC DRUG TO MARKET TO PROVIDE MORE AFFORDABLE ALTERNATIVE TO HIGH-PRICED BIG PHARMA PRODUCTS

Private Sector and Non-Profit Partners Introduce Cancer Treatment That Can Save Patients Thousands of Dollars Per Month In case you missed it, CivicaScript

08-3-2022 Read More

View All

The Crisis

Drug prices are out-of-control. At a time when one-in-four Americans cannot afford their medication, Big Pharma is posting record profits – doubling down on monopolistic tactics to game America’s patent system, prevent generic and biosimilar competition and patient choice and pad their bottom lines.

No patient should ever have to choose between paying for their daily needs or taking the medicine they need to live. Every person deserves access to the medications they need at a price they can afford, especially those who can least afford them.

 

Learn More

Solutions

Americans deserve choice and control over their health. We must all work together to promote competition and increase access to high-quality, affordable treatments and cures for patients. It’s time for real solutions that can deliver more choices, more competition, and lower drug prices by addressing the root causes of price gouging:

Affordability: Too often patients experience the unfortunate and unfair choice between purchasing the medications they need to be well and paying for other necessities. Patients should never be presented with such a choice – especially today with so many people across the U.S. experiencing significant health and economic hardship due to the COVID-19 pandemic. Measures must be taken to improve prescription drug affordability for patients and taxpayers alike, especially while the nation continues to battle the COVID-19 pandemic and everyone across the U.S. will need access to acceptably-priced and affordable virus countermeasures.

Transparency: Patients deserve open and honest drug pricing – clear and transparent information about the true costs of treatment, how manufacturers set prices and the actual cost of bringing drugs to market, particularly for high-cost drugs. Improving pricing transparency will enable patients to become actively involved in their healthcare decision-making and put pressure on Big Pharma to lower the prices of their excessively costly drugs.

Competition: Pharmaceutical companies today abuse the patent system to prevent more affordable drugs from disrupting their monopolies over the drug marketplace. Bringing more competition to the prescription drug market will give consumers more choices and more control – resulting in lower prices and improved access.

Value: Patients deserve reliable information regarding whether a drug’s “therapeutic outcome” – or its health benefit – is in line with its price. This information is critical to moving America’s prescription drug market toward a system that empowers doctors and patients to choose medications based on the value they provide – not the “value” set by drug manufacturers.

Learn More

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.

Who we are

The Campaign for Sustainable Rx Pricing (CSRxP) is a broad-based coalition of leaders – physicians, nurses, hospitals, consumers, health plans, PBMs, pharmacists, and businesses – promoting bipartisan, market-based solutions to lower drug prices in America.

Keep the Conversation Going

Comments Box SVG iconsUsed for the like, share, comment, and reaction icons

The U.S. Senate passage of the Inflation Reduction Act of 2022 will help provide relief to patients & hold #BigPharma accountable for their egregious #drugpricing practices. We encourage the U.S. House to swiftly take up and pass these solutions.

www.csrxp.org/csrxp-applauds-senate-for-major-step-toward-holding-big-pharma-accountable-and-lowe...
... See MoreSee Less

19 hours ago